Home › Funds › B Group, Inc. › NRXP
B Group, Inc. position in NRXP
NRX Pharmaceuticals Inc · Health Care
B Group, Inc. reported holding 4,091,767 shares of NRXP (NRX Pharmaceuticals Inc) in its Q2 2026 13F filing — a position valued at US$16.7M, representing 7.86% of its reported portfolio and ranking #4 among its reported holdings. B Group, Inc. has disclosed NRXP holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How B Group, Inc.'s NRXP position evolved
B Group, Inc. first disclosed a stake in NRXP in Q1 2026 at 3,000,000 shares (US$6.4M). The position peaked in Q2 2026 at 4,091,767 shares, worth US$16.7M. Across 2 filings, B Group, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,091,767 shares valued at US$16.7M — an increase of 1,091,767 shares quarter over quarter.. Notable position changes include a 36% increase in Q2 2026 (shares fell 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 3.00M | $6.39M | New |
| Q2 2026 | 4.09M | $16.74M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NRXP and 13F data
NRXP (NRX Pharmaceuticals Inc) is a Health Care company. 47 other funds we track also report a position in NRXP — the largest reported positions include AdvisorShares Investments LLC (US$2.7M), SJBENEN ADVISORY, LLC (US$42K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NRXP
- AdvisorShares Investments LLC 659.02K sh · $2.70M · Q2 2026
- SJBENEN ADVISORY, LLC 15.00K sh · $41.98K · Q3 2026
More on B Group, Inc.
FAQ
How long has B Group, Inc. held NRXP?
B Group, Inc. has disclosed NRXP holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is B Group, Inc.'s current position in NRXP?
As of Q2 2026, B Group, Inc. holds 4.09M shares of NRXP (NRX Pharmaceuticals Inc), valued at $16.74M, representing 7.86% of its reported portfolio and ranking #4.
Has B Group, Inc. been buying or selling NRXP?
In the latest 13F filing (Q2 2026), B Group, Inc. increased its position in NRXP. The position peaked in Q2 2026 at 4.09M shares.
Which other funds hold NRXP?
Other major institutional holders of NRXP include AdvisorShares Investments LLC, SJBENEN ADVISORY, LLC, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.